Loading chat...
MD SB490
Bill
Status
2/2/2026
Primary Sponsor
Clarence Lam
Click for details
AI Summary
-
Prohibits the Maryland Medical Assistance Program from requiring prior authorization for prescription drugs treating adult enrollees diagnosed with bipolar disorder, schizophrenia, major depression, PTSD, or medication-induced movement disorders related to serious mental illness treatment, except as required under federal law (42 U.S.C. § 1396A)
-
Bans step therapy or fail-first protocols for prescription drugs used to treat the same serious mental illness conditions for all enrollees (adults and children)
-
Takes effect July 1, 2026
-
Includes a 3-year sunset provision, automatically expiring on June 30, 2029 without further legislative action
Legislative Description
Maryland Medical Assistance Program - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription Drugs to Treat Serious Mental Illness
Drugs
Last Action
Hearing 2/17 at 1:00 p.m.
2/3/2026